3 AI Penny Stocks To Own In October 2026

OpenAI cutting its funding target by US$10b has put a harsh spotlight on how much cash big AI projects already consume. That wobble at the top creates an opening further down the market. Smaller AI-focused stocks with lower profiles but ambitious technology can sometimes offer more room for upside if their ideas catch on. This piece highlights three such early stage AI penny stocks worth knowing about.

The three AI penny stocks covered next are just a sample. The full screen surfaces 18 more early stage companies with similarly ambitious stories that are not covered in this article. To go deeper, head straight into the AI Penny Stocks screener to identify, filter, and analyze the highest conviction ideas.

Overview: SEERS develops medical devices such as wearable biosensors and monitoring software, where its medical AI engine supports clinical decisions from patient data.

Operations: SEERS reports about ₩97,050 million in medical equipment revenue, with almost all sales generated in South Korea and only a small overseas contribution.

Market Cap: ₩858.9 billion

SEERS integrates AI directly into hospital workflows through its medical AI engine that interprets wearable biosensor and ECG data for clinicians. The business is now profitable, focused on medical equipment, and recently secured ₩110 billion of convertible bond funding allocated to this software line. Potential returns from this stock depend heavily on how that single capital allocation decision affects pricing power and margins.

If that capital bet is what matters most for SEERS, view the 3 key rewards and 2 important warning signs (1 is major!) to see how upside potential stacks up against the pressure points.

KOSDAQ:A458870 Revenue & Expenses Breakdown as at Oct 2026

Overview: Finatext Holdings builds cloud-based financial infrastructure, front-end fintech apps, and AI driven data analytics that support trading, credit scoring, and personalized financial services for financial and real-estate clients.

Operations: Finatext Holdings generates ¥1,611 million from Fintech Shift, ¥3,205 million from Big Data Analysis, and ¥6,976 million from Financial Infrastructure.

Market Cap: ¥68.1 billion

Finatext Holdings fits the AI Penny Stocks theme through its AI and machine learning analytics for banks and real-estate platforms, which operate on a sizeable financial infrastructure base and trade at a P/E of 39.8x. For investors focused on early stage AI plays, key considerations include how its data-heavy business unit may influence pricing power and margin resilience over time.

Those margin questions are central to the real story. See the 3 key rewards and 1 important major warning sign to evaluate how Finatext Holdings’ AI ambitions compare with the key pressure points that matter.

TSE:4419 P/E Ratio as at Oct 2026

Overview: M31 Technology supplies silicon IP and integration services that enable AI accelerators, edge AI chips, and broader integrated circuit designs.

Operations: M31 Technology records NT$1,716 million from semiconductor equipment and services, with this line representing its primary reported revenue base.

Market Cap: NT$17.7 billion

M31 Technology provides exposure to AI at the chip design level through IP that helps power AI accelerators and edge devices. Recent alliances with Ambiq and Rambus link its circuitry to energy efficient AIoT and imaging workloads. The company’s outlook will depend in part on how its pipeline of design wins develops over time.

That pipeline question is the real hinge for M31 Technology, so head to the 3 key rewards and 1 important warning sign to see how design win momentum could overpower the weak spots.

TPEX:6643 Earnings & Revenue History as at Oct 2026

Seeking Fresh Alternatives Before They Fly

Markets move fast, and prominent breakout stories rarely stay under the radar for long. Spot fresh momentum ideas before they become widely followed and consider acting early in your own process.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com